Preleukemic States

Preleukemic States
Section I: Clinical and Hematological Data
The Preleukemic Syndrome: Clinical and Laboratory Features, Natural Course, and Management
Preleukemic States. I. Definition and Classification. II. Refractory Anemia with an Excess of Myeloblasts in the Bone Marrow (Smoldering Acute Leukemia)
Preleukemic States in Atomic Bomb Survivors in Japan
Acute Myeloblastic Leukemia after Immunodepressive Therapy for Primary Nonmalignant Disease
Preleukemia: Does it Exist?
Section II: New Techniques and Special Investigations
Prediction of Relapse and Remission in AML by Marrow Culture Criteria
In vitro Colony Growth of Acute Myelogenous Leukemia
The Use of the Robinson in vitro Agar Culture Assay in Adult Acute Leukemia
Significance of PHA Induced Clonogenic Cells in Chronic Myeloid Leukemia and Early Acute Myeloid Leukemia
An Approach to Human Preleukemia Using Cell Culture Studies
Comparative Electron-Microscopic Study of the Erythrocytic Line in Refractory Anemia (Preleukemia) and Myelomonocytic Leukemia
Cytochemical and Ultrastructural Studies of Aberrant Granules in the Neutrophils of Two Patients with Myeloperoxidase Deficiency during a Preleukemic State. Relationship to Abnormal Bactericidal Activity
Blood Groups Changes in Preleukemic States
The Cellular Distribution of Erythrocyte and Normoblast A1and A Antigens in Normal and Preleukemic States. An Immunoelectron Microscopy Study
Abnormal Distribution of Erythrocytes A1 Antigens in Preleukemia as Demonstrated by an Immunofluorescence Technique
Cell Membrane Antigens Associated with Human Adult Acute Leukemia
Section III: Pathophysiology
Notions about Human Stem Cells
Preleukemic States in the Light of the Leukemia Cytokinetics
The Role of Lymphoid and Haematopoietic Target Cells in Viral Lymphomagenesis of C57BL/Ka Mice. I. Susceptibility to Viral Replication
The Role of Lymphoid and Haematopoietic Target Cells in Viral Lymphomagenesis of C57BL/Ka Mice. II. Neoplastic Transformation of Bone Marrow-Derived Cells in the Thymic Microenvironment
Oncogenesis in Human Acute Leukemia
Problems Relating to Immunoselection of Leukemias
Section IV: General Discussion
I. Is Preleukemic States an Adequate Designation?
II. Should Hemopoietic Dysplasias be Treated?
III. A Registry for Hemopoietic Dysplasias.